Jardiance 25mg (empagliflozin) is an oral pill taken by type 2 diabetic patients to help control blood sugar levels. It is also used to reduce the risk of heart attack, stroke or heart failure among people suffering from type 2 diabetes. Empagliflozin helps the kidneys to eliminate glucose from the bloodstream, thereby controlling the blood sugar levels.

Jardiance 25mg should not be taken by people with type 1 diabetes, severe kidney disease or who are undergoing dialysis.

Jardiance 25mg is often suggested along with diet and exercise in order for it to be highly effective in controlling blood sugar levels. The commonly recommended dosage for Jardiance is 10mg taken every morning. The dosage can be increased to 25mg for patients who are tolerating Jardiance.

Jardiance is approved by the U.S. Food and Drug Administration after its safety and effectiveness were tested in seven clinical trials with over 4500 people suffering from type 2 diabetes.

Medicare offers coverage for Jardiance 25mg prescription drugs. Medicare Part D and Medicare Advantage plans cover this drug by 67%. Medicare Part A and Part B do not offer coverage on prescription drugs. You can either purchase a Medicare Advantage plan that includes prescription drug coverage or opt for Medicare Part D, which is an individual plan.

The Medicare Part D prescription drug plan sold by UnitedHealthcare includes premiums, copays, coinsurance, and deductibles. Medicare sets the guidelines and plan prices that in turn decide the drug costs. UnitedHealth care offers prescription drug plans on Jardiance 25mg which will help you save money on your prescriptions.

You can enroll in a Medicare Prescription Drug Plan online through UnitedHealthcare. You can avail important information related to enrollment such as premium payment information, related forms, pharmacy directory, plans and pricing on the UnitedHealthcare website. Plans range from those offering low premiums and broad pharmacy network to those offering robust prescription drug coverage.